Pfizer, Searle pick Lally for new drugs

Published on .

Joint marketers Pfizer and the Searle division of Monsanto Co. have tapped Lally, McFarland & Pantello/Euro RSCG to serve as the launch agency for the next-generation of arthritis-treatment prescription drugs after Celebrex, executives close to the marketer said. Lally may play a role in giving the drugs brand names.

Copyright January 2000, Crain Communications Inc.

Most Popular
In this article: